Effects of 2-(2-benzofuranyl)-2-imidazoline (2-BFI) on dopamine synthesis in rat striatum in vivo.
Sastre-Coll
A
A
Laboratory of Neuropharmacology, University of the Balearic Islands, Palma de Mallorca, Spain.
Esteban
S
S
García-Sevilla
J A
JA
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D001572:Benzofurans / Q000494:pharmacology*; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000096:biosynthesis* / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D007093:Imidazoles / Q000494:pharmacology*; D054755:Imidazoline Receptors; D008024:Ligands; D008995:Monoamine Oxidase / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D009928:Organ Specificity; D051381:Rats; D011955:Receptors, Drug / Q000502:physiology
D001572:Benzofurans; D007093:Imidazoles; D054755:Imidazoline Receptors; D008024:Ligands; D011955:Receptors, Drug; D015102:3,4-Dihydroxyphenylacetic Acid; C103723:2-(2-benzofuranyl)-2-imidazoline; D008995:Monoamine Oxidase; D004298:Dopamine; D009638:Norepinephrine